Skip to main content
SpringerLink
Log in

Therapie der Multiplen Sklerose

Glatirameracetat oder Interferon-Präparate — was wirkt stärker?

  • journal club
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Kalincik T, Jokubaitis V, Izquierdo G et al; on behalf of the MSBase Study Group; on behalf of the MSBase Study Group. Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis. Mult Scler 2014 Dec 5. pii: 1352458514559865. [Epub ahead of print]

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologische Klinik, Ruhr-Universität Bochum, Bochum, Deutschland

    Simon Faissner &  Andrew Chan

Authors
  1. Simon Faissner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simon Faissner.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Faissner, S., Chan, A. Glatirameracetat oder Interferon-Präparate — was wirkt stärker?. InFo Neurologie 17, 28 (2015). https://doi.org/10.1007/s15005-015-1313-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-015-1313-0

Search

Navigation